Reassessing Use of Depot Medroxyprogesterone Acetate in Select Groups of Women: Applying the 2024 U.S. Centers for Disease Control and Prevention Medical Eligibility Criteria for Contraceptive Use Guidelines
Journal of Women's Health | June 26, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
10.1177/15409996261464847